Hepatitis A vaccine: is it being used to best advantage?
Scheifele
David W
DW
Vaccine Evaluation Center, British Columbia's Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver. dscheifele@cw.bc.ca
Ochnio
Jan
J
D000293:Adolescent; D000328:Adult; D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control*; D005260:Female; D006301:Health Services Needs and Demand; D006506:Hepatitis A / Q000453:epidemiology / Q000517:prevention & control*; D022362:Hepatitis A Vaccines; D006801:Humans; D017589:Immunization Programs; D008297:Male; D008875:Middle Aged; D014481:United States / Q000453:epidemiology
D022362:Hepatitis A Vaccines